The USRDS: What you need to know about what it can and can't tell us about ESRD

Rob Foley, Allan J Collins

Research output: Contribution to journalArticlepeer-review

88 Scopus citations

Abstract

This article summarizes the administrative structure underlying the Unites States Renal Data System (USRDS); summarizes incidence, prevalence, patient characteristics, and treatment modalities; and describes data regarding clinical indicators and preventive care, hospitalization, survival, and costs. The USRDS recently instituted a comprehensive assessment system to characterize the transition to the new Centers for Medicare & Medicaid Services Prospective Payment System, which bundles into a single payment several integral components of dialysis care. This challenging initiative will be an important component of future USRDS Annual Data Reports. The main strengths of the USRDS are its size and representativeness, nearly complete inclusion of the US end-stage renal disease population, and linkage to Medicare claims. Limitations include lack of continuous validation of its methods, lack of complete comorbidity and laboratory data at registration, an initial survival bias, and lack of accuracy of cause-of-death reporting.

Original languageEnglish (US)
Pages (from-to)845-851
Number of pages7
JournalClinical Journal of the American Society of Nephrology
Volume8
Issue number5
DOIs
StatePublished - May 7 2013

Fingerprint Dive into the research topics of 'The USRDS: What you need to know about what it can and can't tell us about ESRD'. Together they form a unique fingerprint.

Cite this